Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Characterization of a versatile organometallic pro-drug (CORM) for experimental CO based therapeutics.

Characterization of a versatile organometallic pro-drug (CORM) for experimental CO based therapeutics. Dalton Trans. 2013 May 07; 42(17):5985-98.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.